Report Feature
The future of the global viral inactivation market looks promising with opportunities in applications, such as stem cell products, blood and blood related products, tissues & tissue related products, cellular & gene therapy products, and vaccines & therapeutics. The global viral inactivation market is expected to grow with a CAGR of 11%-13% from 2020 to 2025. The major drivers for this market are rising investment in the life science sector, increasing launches & approvals for new drugs, and government support in funding for the development of the pharmaceutical and biopharmaceutical industries.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global viral inactivation market report, please download the report brochure.
In this market, kits and reagents is the largest product type of viral inactivation, whereas pharmaceutical and biotechnology companies is the largest end user. Growth in various segments of the viral inactivation market are given below:
The study includes trends and forecast for the global viral inactivation market by product, method, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
- Kits & Reagents
- Services
- Systems & Accessories
By Method [Value ($ Million) shipment analysis for 2014 – 2025]:
- Solvent Detergent
- Pasteurization
- Other Methods
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Stem Cell Products
- Blood and Blood Products
- Tissues & Tissue Products
- Cellular & Gene Therapy Products
- Vaccines & Therapeutics
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic Research Institutes
- Other End Users
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Spain
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Some of the viral inactivation companies profiled in this report include Clean Cells, Charles River Laboratories International, Danaher, Merck, Parker Hannifin, Rad Source Technologies, Sartorius, SGS, Texcell, and Viral Inactivated Plasma Systems.
Lucintel forecasts that kits & reagents will remain the largest segment over the forecast period due to growth in the pharmaceutical and biotechnology industries and rising R&D spending for new drug development.
Within this market, pharmaceutical and biotechnology companies will remain the largest end user segment over the forecast period because increasing investment to find alternative therapies has increased the development of new drugs and introduction of biologics and other cellular & gene therapy products.
North America will remain the largest region over the forecast period due to the presence of advanced healthcare infrastructure and significant expenditure on research and development activities by the government and companies in the region.
|
Features of the Global Viral Inactivation Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global viral inactivation market by product (kits & reagents, services, and systems & accessories), method (solvent detergent, pasteurization, and other methods), application (stem cell products, blood & blood products, tissues & tissue products, cellular & gene therapy products, and vaccines & therapeutics), end user (pharmaceutical and biotechnology companies, CROs, academic research institutes, and other end users), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global viral inactivation market? Q.5 What are the business risks and threats to the global viral inactivation market? Q.6 What are the emerging trends in this viral inactivation market and the reasons behind them? Q.7 What are some changing demands of customers in this viral inactivation market? Q.8 What are the new developments in this viral inactivation market? Which companies are leading these developments? Q.9 Who are the major players in this viral inactivation market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this viral inactivation market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global viral inactivation market? |
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product (Kits & Reagents, Services, and Systems & Accessories), Method (Solvent Detergent, Pasteurization, and Other Methods), Application (Stem Cell Products, Blood & Blood Products, Tissues & Tissue Products, Cellular & Gene Therapy Products, and Vaccines & Therapeutics), and End User (Pharmaceutical And Biotechnology Companies, CROs, Academic Research Institutes, and Other End Users) |
|
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Viral Inactivation Market
4.1 Global Viral Inactivation Market by Region
4.2.1 Market by Product: Kits & Reagents, Services, and Systems & Accessories
4.2.2 Market by Method: Solvent Detergent, Pasteurization, and Other Methods
4.2.3 Market by Application: Stem Cell Products, Blood & Blood Products, Tissues & Tissue Products, Cellular & Gene Therapy Products, and Vaccines & Therapeutics
4.2.4 Market by End User: Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic Research Institutes, and Other End Users
4.2.5 The United States Viral Inactivation Market
4.2.6 The Canadian Viral Inactivation Market
4.2.7 The Mexican Viral Inactivation Market
4.3.1 Market by Product: Kits & Reagents, Services, and Systems & Accessories
4.3.2 Market by Method: Solvent Detergent, Pasteurization, and Other Methods
4.3.3 Market by Application: Stem Cell Products, Blood & Blood Products, Tissues & Tissue Products, Cellular & Gene Therapy Products, and Vaccines & Therapeutics
4.3.4 Market by End User: Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic Research Institutes, and Other End Users
4.3.5 The Viral Inactivation Market of United Kingdom
4.3.6 The Spanish Viral Inactivation Market
4.3.7 The German Viral Inactivation Market
4.3.8 The French Viral Inactivation Market
4.4.1 Market by Product: Kits & Reagents, Services, and Systems & Accessories
4.4.2 Market by Method: Solvent Detergent, Pasteurization, and Other Methods
4.4.3 Market by Application: Stem Cell Products, Blood & Blood Products, Tissues & Tissue Products, Cellular & Gene Therapy Products, and Vaccines & Therapeutics
4.4.4 Market by End User: Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic Research Institutes, and Other End Users
4.4.5 The Chinese Viral Inactivation Market
4.4.6 The Indian Viral Inactivation Market
4.4.7 The Japanese Viral Inactivation Market
4.5.1 Market by Product: Kits & Reagents, Services, and Systems & Accessories
4.5.2 Market by Method: Solvent Detergent, Pasteurization, and Other Methods
4.5.3 Market by Application: Stem Cell Products, Blood & Blood Products, Tissues & Tissue Products, Cellular & Gene Therapy Products, and Vaccines & Therapeutics
4.5.4 Market by End User: Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic Research Institutes, and Other End Users
4.5.5 Brazilian Viral Inactivation Market
7.1.1 Growth Opportunities for the Global Viral Inactivation Market by Product
7.1.2 Growth Opportunities for the Global Viral Inactivation Market by Method
7.1.3 Growth Opportunities for the Global Viral Inactivation Market by Application
7.1.5 Growth Opportunities for the Global Viral Inactivation Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
